Cargando…
The Management of Oligoprogression in the Landscape of New Therapies for Metastatic Melanoma
Background: A limited degree of progression after a response to treatment is labelled as oligoprogression and is a hot topic of metastatic melanoma (MM) management. Rogue progressive metastases could benefit from local treatment, which could allow the continuation of ongoing systemic therapy, also k...
Autores principales: | Guida, Michele, Bartolomeo, Nicola, De Risi, Ivana, Fucci, Livia, Armenio, Andrea, Filannino, Ruggero, Ruggieri, Eustachio, Macina, Francesco, Traversa, Michele, Nardone, Annalisa, Figliuolo, Francesco, De Luca, Federica, Mele, Fabio, Tommasi, Stefania, Strippoli, Sabino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826412/ https://www.ncbi.nlm.nih.gov/pubmed/31615127 http://dx.doi.org/10.3390/cancers11101559 |
Ejemplares similares
-
Cemiplimab in an Elderly Frail Population of Patients With Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Center Real-Life Experience From Italy
por: Strippoli, Sabino, et al.
Publicado: (2021) -
Cellular analysis of bronchoalveolar lavage fluid to narrow differential diagnosis of checkpoint inhibitor-related pneumonitis in metastatic melanoma
por: Strippoli, Sabino, et al.
Publicado: (2020) -
Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma
por: Serratì, Simona, et al.
Publicado: (2023) -
Examining the Relationship between Circulating CD4− CD8− Double-Negative T Cells and Outcomes of Immuno-Checkpoint Inhibitor Therapy—Looking for Biomarkers and Therapeutic Targets in Metastatic Melanoma
por: Strippoli, Sabino, et al.
Publicado: (2021) -
A deep learning model based on whole slide images to predict disease-free survival in cutaneous melanoma patients
por: Comes, Maria Colomba, et al.
Publicado: (2022)